These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 776335)

  • 1. Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal disease.
    Galbraith RM; el Sheikh N; Portmann B; Eddleston AL; Williams R; Parsons V; Bewick M; Ogg CS
    Br Med J; 1976 Jun; 1(6024):1495-7. PubMed ID: 776335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis in end-stage renal disease: comparison of HBsAg-negative and HBsAg-positive patients.
    Parfrey PS; Farge D; Forbes RD; Dandavino R; Kenick S; Guttmann RD
    Kidney Int; 1985 Dec; 28(6):959-67. PubMed ID: 3936966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver disease and the e antigen in HBsAg carriers with chronic renal failure.
    Coughlin GP; Van Deth AG; Disney AP; Hay J; Wangel AG
    Gut; 1980 Feb; 21(2):118-22. PubMed ID: 7380332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients.
    Parfrey PS; Forbes RD; Hutchinson TA; Beaudoin JG; Dauphinee WD; Hollomby DJ; Guttmann RD
    Transplantation; 1984 May; 37(5):461-6. PubMed ID: 6375001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis.
    Degott C; Degos F; Jungers P; Naret C; Courouce AM; Potet F; Crosnier J
    Liver; 1983 Dec; 3(6):377-84. PubMed ID: 6366422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era.
    Yagisawa T; Toma H; Tanabe K; Ishikawa N; Tokumoto N; Iguchi Y; Goya N; Nakazawa H; Takahashi K; Ota K
    Am J Nephrol; 1997; 17(5):440-4. PubMed ID: 9382163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients.
    Ray MB; Desmet VJ; Bradburne AF; Desmyter J; Fevery J; De Groote J
    Gastroenterology; 1976 Sep; 71(3):462-9. PubMed ID: 59675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis in kidney allograft recipients.
    Pol S; Debure A; Degott C; Carnot F; Legendre C; Brechot C; Kreis H
    Lancet; 1990 Apr; 335(8694):878-80. PubMed ID: 1969984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic histology in chronic liver disease in hepatitis B surface antigen positive cases.
    Ghosh AK; Dasgupta A; Raha K; Jana A; Majumdar DN
    J Indian Med Assoc; 1994 Oct; 92(10):333-5. PubMed ID: 7822848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
    Kim JA; Huh W; Lee KW; Kim SJ; Kim YG; Kim DJ; Joh JW; Oh HY
    Transplant Proc; 2004 Jun; 36(5):1434-7. PubMed ID: 15251352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation.
    Ben-Ari Z; Broida E; Kittai Y; Chagnac A; Tur-Kaspa R
    Am J Gastroenterol; 2000 Dec; 95(12):3579-83. PubMed ID: 11151895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis with Australia antigenemia following renal transplantation.
    Aronoff A; Gault MH; Huang SN; Lal S; Wu KT; Moinuddin MD; Spence L; MacLean LD
    Can Med Assoc J; 1973 Jan; 108(1):43-50. PubMed ID: 4566289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.
    de Moura MC; Vernace SJ; Paronetto F
    Gastroenterology; 1975 Aug; 69(2):310-17. PubMed ID: 1080122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of renal transplantation on the course of hepatitis B liver disease.
    Parfrey PS; Forbes RD; Hutchinson TA; Kenick S; Farge D; Dauphinee WD; Seely JF; Guttmann RD
    Transplantation; 1985 Jun; 39(6):610-5. PubMed ID: 3890290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E antigen in the serum of HBs antigen-positive patients on maintenance dialysis and after transplantation.
    Albert FW; Brisam A; Traut G; Thamer G
    Proc Eur Dial Transplant Assoc; 1978; 15():306-11. PubMed ID: 368777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver disease in patients undergoing hemodialysis and kidney transplantation.
    Toussaint C; Dupont E; Vanherweghem JL; Cappel R; De Roy G; Vereerstraeten P; Kinnaert P; Thiry L; Van Geertruyden J
    Adv Nephrol Necker Hosp; 1979; 8():269-94. PubMed ID: 115244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between hepatitis B antigen, e-antigen, and liver-pathology in patients treated with dialysis.
    Nordenfelt E; Lindholm T; Henrikson H
    Scand J Urol Nephrol; 1975; 9(3):277-81. PubMed ID: 1209185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity to hepatitis B surface antigen in blood donors with persistent antigenaemia.
    Lee WM; Reed WD; Mitchell CG; Woolf IL; Dymock IW; Eddleston AL; Williams R
    Gut; 1975 Jun; 16(6):416-20. PubMed ID: 1080125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.
    Bang BK; Yang CW; Yoon SA; Kim YS; Chang YS; Yoon YS; Koh YB
    Nephron; 1995; 70(4):397-401. PubMed ID: 7477642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.